Close Menu

NEW YORK ─ Siemens Healthineers said Wednesday it has received the CE mark for its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay, allowing for its use as a clinical diagnostic test in Europe.

The firm also registered the test with the Luxembourg Ministry of Health and said it plans to ship more than 1.3 million tests per month worldwide as production capacity increases in May.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US has sent its formal notice of withdrawal from the World Health Organization, according to the Wall Street Journal.

Science reports that a draft spending bill would increase the US National Institutes of Health budget by 13 percent.

The Harvard Crimson reports that Harvard and MIT are suing the Department of Homeland Security and ICE over the new international student visa policy.

In Nucleic Acids Research this week: algorithm to determine molecular sequence types and other microbial features, computational method to uncover R-loop structures, and more.